NCT03625570

Brief Summary

Ambulatory children with cerebral palsy (CP) experience walking limitations which negatively influence their ability to physically participate in day to day life. The investigators propose that impaired muscle power generation is the key limiting factor affecting walking activity and participation. This proposal represents a combined approach where participants undergo resistance training for muscle power generation in combination with locomotor treadmill training that is based on typical pediatric walking and activity patterns rather than adult protocols, which are endurance or time-based. Therefore, the primary objective of this randomized controlled trial is to determine the effect of lower extremity Power Training combined with interval Treadmill Training (PT³) on functional walking capacity and community-based activity and participation in children with CP. We hypothesize that remediating the most pronounced muscle performance impairment (i.e., muscle power) with power training combined with a task- specific approach to walking that is developmentally appropriate will have a significant effect on walking capacity and performance.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 1, 2018

Completed
9 days until next milestone

First Posted

Study publicly available on registry

August 10, 2018

Completed
8 months until next milestone

Study Start

First participant enrolled

April 15, 2019

Completed
4.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 4, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 10, 2023

Completed
1.1 years until next milestone

Results Posted

Study results publicly available

December 13, 2024

Completed
Last Updated

December 13, 2024

Status Verified

November 1, 2024

Enrollment Period

4.5 years

First QC Date

August 1, 2018

Results QC Date

October 4, 2024

Last Update Submit

November 20, 2024

Conditions

Keywords

muscle weaknessmuscle powerresistance trainingtreadmill training

Outcome Measures

Primary Outcomes (4)

  • Change in Self-selected Gait Speed (Normalized)

    Calculated from the 10 meter walk test in meters/second at self-selected speed and then normalized by stature to yield non-dimensional units. Higher values represent faster gait speeds.

    Baseline and immediate post training (8-10 weeks post baseline)

  • Change in Fast Gait Speed (Normalized)

    Calculated from the 10 meter walk test in meters/second at fast walking speed and then normalized by stature to yield non-dimensional units. Higher values equal faster gait speeds.

    Baseline and immediate post training (8-10 weeks post baseline)

  • Change in Peak Power

    Lower extremity peak power produced during a power leg press test averaged over 5 trials; product of force x velocity; adjusted for sled angle and body mass

    Baseline and immediate post training (8-10 weeks post baseline)

  • Change in Average Strides Per Day

    Average number of strides walked per day captured by Step Watch accelerometer as worn for a minimum of 4 days

    Baseline and immediate post training (8-10 weeks post baseline)

Secondary Outcomes (10)

  • Change in Self-selected Gait Speed (Normalized)

    Baseline and 2 months post training (16 weeks post baseline)

  • Change in Fast Gait Speed (Normalized)

    Baseline and 2 months post training (16 weeks post baseline)

  • Change in Peak Power

    Baseline and 2 months post training (16 weeks post baseline)

  • Change in Average Strides Per Day

    Baseline and 2 months post training (16 weeks post baseline)

  • Change in One Minute Walk Test

    Baseline and immediate post training (8-10 weeks post baseline)

  • +5 more secondary outcomes

Study Arms (2)

PT³

EXPERIMENTAL

Power Training combined with interval treadmill training

Behavioral: Power training combined with interval treadmill training

Traditional training

ACTIVE COMPARATOR

Strength training combined with traditional treadmill training

Behavioral: Strength training combined with traditional treadmill training

Interventions

Training will consist of unilateral and bilateral leg presses, targeting the quadriceps, hip extensors, and plantarflexors according to resistance training guidelines for muscle power training. The interval treadmill training portion will include short-bursts (30 seconds) of high speed walking intervals alternating with 30 seconds of low to moderate speed walking for a total of 30 minutes. Participants will train 3 x per week for 8 weeks. Total duration of each session will be approximately 1 hour.

PT³

Training will consist of unilateral and bilateral leg presses, targeting the quadriceps, hip extensors, and plantarflexors following the dosing and resistance training guidelines for muscle strength. Traditional treadmill training will consist of walking at steady-state speeds for 30 minutes. Participants will train 3 x per week for 8 weeks. Total duration of each session will be approximately 1 hour.

Traditional training

Eligibility Criteria

Age10 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Diagnosis of bilateral spastic Cerebral Palsy (CP)
  • Age 10 to 17 years inclusive
  • GMFCS levels I, II, or III

You may not qualify if:

  • Orthopedic or neurosurgery less than 12 months prior to enrollment
  • Injection therapies (phenol, botulinum toxin) less than 3 months prior to enrollment
  • Lacking greater than 25 degrees of knee extension

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Louisiana State University Health Sciences Center

New Orleans, Louisiana, 70112, United States

Location

Seattle Children's Hospital

Seattle, Washington, 98121, United States

Location

MeSH Terms

Conditions

Cerebral PalsyCentral Nervous System DiseasesBrain Damage, ChronicMuscle Weakness

Condition Hierarchy (Ancestors)

Brain DiseasesNervous System DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsMuscular DiseasesMusculoskeletal DiseasesNeuromuscular ManifestationsNeurologic ManifestationsSigns and Symptoms

Results Point of Contact

Title
Dr. Noelle G. Moreau
Organization
Louisiana State University Health Sciences Center - New Orleans

Study Officials

  • Noelle G Moreau, PT, PhD

    Louisiana State University Health Sciences Center - New Orleans

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 1, 2018

First Posted

August 10, 2018

Study Start

April 15, 2019

Primary Completion

October 4, 2023

Study Completion

November 10, 2023

Last Updated

December 13, 2024

Results First Posted

December 13, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Locations